IFNA1 and COVID-19: A higher dose of TLR7 expression has been suggested to lead to higher IFN signaling in acute COVID-19 and better viral clearance in females, though continued IFN signaling may lead to overactive immune activation and persistent inflammation, predisposing females to a higher autoimmunity risk and PASC [9, 31].